Study identifier:NIS-RFR-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Evaluation of the control level (GINA) of asthmatic patients consulting their general practitioner for a seasonal increase of respiratory symptoms (high and / or low), whether an inhaled corticotherapy is taken or not
asthma
-
No
-
All
3300
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2009 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
To evaluate the level of control of Asthma (GINA : controlled, partially controlled, not controlled) of asthmatic patients consulting their general practitioner for a seasonal increase of respiratory symptoms (high and / or low) whether an inhaled corticotherapy is taken or not.
Location
Location
ABBARETZ, France
Location
ACHEUX EN AMIENOIS, France
Location
AGEN, France
Location
AGNEAUX, France
Location
AGON COUTAINVILLE, France
Location
AIGNAY LE DUC, France
Location
AIGUILLON, France
Location
AISEREY, France
Arms | Assigned Interventions |
---|---|
1 | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.